ArticleCancer management and research2015

Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases receiving antiandrogen therapy.

Abby Holt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.